The presence of androgen receptor elements regulates ZEB1 expression in the absence of androgen receptor

Journal of Cellular Biochemistry

Volumn 116, Issue 1, 2015, Pages 115-123

  Mooney, Steven M ^c   Parsana, Princy ^c   Hernandez, James R ^c   Liu, Xin ^a,c   Verdone, James E ^c   Torga, Gonzalo ^c   Harberg, Calvin A ^b,c   Pienta, Kenneth J ^c  

^a FUDAN UNIVERSITY   (China)

^b UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Androgen Receptor (AR); Epithelial to mesenchymal transition (EMT); Luciferase assays; OVOL1; OVOL2; Prostate cancer; ZEB1 TCF8

Indexed keywords

ANDROGEN RECEPTOR; ANDROGEN RECEPTOR ELEMENT; LUCIFERASE; METRIBOLONE; PROSTATE SPECIFIC ANTIGEN; TRANSCRIPTION FACTOR ZEB1; UNCLASSIFIED DRUG; UVOMORULIN; AR PROTEIN, HUMAN; HOMEODOMAIN PROTEIN; TRANSCRIPTION FACTOR; ZEB1 PROTEIN, HUMAN;

ARTICLE; CANCER CELL LINE; CONTROLLED STUDY; EPITHELIAL MESENCHYMAL TRANSITION; IN VIVO STUDY; LNCAP CELL LINE; POLYMERASE CHAIN REACTION; PROMOTER REGION; PROSTATE CANCER; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; TRANSCRIPTION INITIATION; UPREGULATION; GENE EXPRESSION REGULATION; GENETICS; HUMAN; MALE; METABOLISM; PHYSIOLOGY; PROSTATE TUMOR; TUMOR CELL LINE;

CELL LINE, TUMOR; EPITHELIAL-MESENCHYMAL TRANSITION; GENE EXPRESSION REGULATION, NEOPLASTIC; HOMEODOMAIN PROTEINS; HUMANS; MALE; PROMOTER REGIONS, GENETIC; PROSTATIC NEOPLASMS; RECEPTORS, ANDROGEN; TRANSCRIPTION FACTORS; ZINC FINGER E-BOX-BINDING HOMEOBOX 1;

EID: 84941035563     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.24948     Document Type: Article

References (27)

1. Anose BM, Sanders MM. 2011. Androgen receptor regulates transcription of the ZEB1 transcription factor. Int J Endocrinol 2011:903918.
2. Cottard F, Asmane I, Erdmann E, Bergerat JP, Kurtz JE, Ceraline J. 2013. Constitutively active androgen receptor variants upregulate expression of mesenchymal markers in prostate cancer cells. PLoS One 8:e63466.
3. Graham TR, Yacoub R, Taliaferro-Smith L, Osunkoya AO, Odero-Marah VA, Liu T, Kimbro KS, Sharma D, O'Regan RM. 2010. Reciprocal regulation of ZEB1 and AR in triple negative breast cancer cells. Breast Cancer Res Treat 123:139-147.
4. Hu R, Dunn TA, Wei S, Isharwal S, Veltri RW, Humphreys E, Han M, Partin AW, Vessella RL, Isaacs WB, Bova GS, Luo J. 2009. Ligand-independent androgen receptor variants derived from splicing of cryptic exons signify hormone-refractory prostate cancer. Cancer Res 69:16-22.
5. Hu R, Lu C, Mostaghel EA, Yegnasubramanian S, Gurel M, Tannahill C, Edwards J, Isaacs WB, Nelson PS, Bluemn E, Plymate SR, Luo J. 2012. Distinct transcriptional programs mediated by the ligand-dependent full-length androgen receptor and its splice variants in castration-resistant prostate cancer. Cancer Res 72:3457-3462.
6. Hugo HJ, Pereira L, Suryadinata R, Drabsch Y, Gonda TJ, Gunasinghe NP, Pinto C, Soo ET, Van Denderen B, Hill P, Ramsay RG, Sarcevic B, Newgreen DF, Thompson EW. 2013. Direct repression of MYB by ZEB1 suppresses proliferation and epithelial gene expression during epithelial-to-mesenchymal transition of breast cancer cells. Breast Cancer Res 15:R113.
7. Kim JJ, Rajagopalan K, Hussain B, Williams BH, Kulkarni P, Mooney SM. 2013. CETN1 is a cancer testis antigen with expression in prostate and pancreatic cancers. Biomark Res 1:22.
8. Kulkarni P, Shiraishi T, Rajagopalan K, Kim R, Mooney SM, Getzenberg RH. 2012. Cancer/testis antigens and urological malignancies. Nat Rev Urol 9:386-396.
9. Li Y, Zeng Y, Mooney SM, Yin B, Mizokami A, Namiki M, Getzenberg RH. 2011. Resistance to paclitaxel increases the sensitivity to other microenvironmental stresses in prostate cancer cells. J Cell Biochem 112:2125-2137.
10. Massie CE, Lynch A, Ramos-Montoya A, Boren J, Stark R, Fazli L, Warren A, Scott H, Madhu B, Sharma N, Bon H, Zecchini V, Smith DM, Denicola GM, Mathews N, Osborne M, Hadfield J, Macarthur S, Adryan B, Lyons SK, Brindle KM, Griffiths J, Gleave ME, Rennie PS, Neal DE, Mills IG. 2011. The androgen receptor fuels prostate cancer by regulating central metabolism and biosynthesis. EMBO J 30:2719-2733.
11. Moes M, Le Bechec A, Crespo I, Laurini C, Halavatyi A, Vetter G, Del Sol A, Friederich E. 2012. A novel network integratinga miRNA-203/SNAI1 feedback loop which regulates epithelial to mesenchymal transition. PLoS One 7:e35440.
12. Mooney SM, Goel A, D'Assoro AB, Salisbury JL, Janknecht R. 2010a. Pleiotropic effects of p300-mediated acetylation on p68 and p72 RNA helicase. J Biol Chem 285:30443-30452.
13. Mooney SM, Grande JP, Salisbury JL, Janknecht R. 2010b. Sumoylation of p68 and p72 RNA helicases affects protein stability and transactivation potential. Biochemistry 49:1-10.
14. Mooney SM, Qiu RR, Kim JJ, Sacho EJ, Rajagopalan K, Johng D, Shiraishi T, Kulkarni P, Weninger KR. 2014. The Cancer/Testis Antigen PAGE4, a Regulator of c-Jun. Transactivation, is Phosphorylated by Homeodomaininteracting Protein Kinase 1, a Component of the Stress-response Pathway. Biochemistry 53(10):1670-1679.
15. Ni L, Llewellyn R, Kesler CT, Kelley JB, Spencer A, Snow CJ, Shank L, Paschal BM. 2013. Androgen induces a switch from cytoplasmic retention to nuclear import of the androgen receptor. Mol Cell Biol 33:4766-4778.
16. Pienta KJ, Bradley D. 2006. Mechanisms underlying the development of androgen-independent prostate cancer. Clin Cancer Res 12:1665-1671.
17. Rajagopalan K, Mooney SM, Parekh N, Getzenberg RH, Kulkarni P. 2011. A majority of the cancer/testis antigens are intrinsically disordered proteins. J Cell Biochem 112:3256-3267.
18. Rajagopalan K, Qiu R, Mooney SM, Rao S, Shiraishi T, Sacho E, Huang H, Shapiro E, Weninger KR, Kulkarni P. 2014. The Stress-response protein prostate-associated gene 4, interacts with c-Jun. and potentiates its transactivation. Biochim Biophys Acta 1842:154-163.
19. Renthal NE, Chen CC, Williams KC, Gerard RD, Prange-Kiel J, Mendelson CR. 2010. MiR-200 family and targets, ZEB1 and ZEB2, modulate uterine quiescence and contractility during pregnancy and labor. Proc Natl Acad Sci USA 107:20828-20833.
20. Roca H, Hernandez J, Weidner S, McEachin RC, Fuller D, Sud S, Schumann T, Wilkinson JE, Zaslavsky A, Li H, Maher CA, Daignault-Newton S, Healy PN, Pienta KJ. 2013. Transcription factors OVOL1 and OVOL2 induce the mesenchymal to epithelial transition in human cancer. PLoS One 8:e76773.
21. Salnikov AV, Liu L, Platen M, Gladkich J, Salnikova O, Ryschich E, Mattern J, Moldenhauer G, Werner J, Schemmer P, Buchler MW, Herr I. 2012. Hypoxia induces EMT in low and highly aggressive pancreatic tumor cells but only cells with cancer stem cell characteristics acquire pronounced migratory potential. PLoS One 7:e46391.
22. Sun Y, Wang BE, Leong KG, Yue P, Li L, Jhunjhunwala S, Chen D, Seo K, Modrusan Z, Gao WQ, Settleman J, Johnson L. 2012. Androgen deprivation causes epithelial-mesenchymal transition in the prostate: implications for androgen-deprivation therapy. Cancer Res 72:527-536.
23. Wang Q, Li W, Zhang Y, Yuan X, Xu K, Yu J, Chen Z, Beroukhim R, Wang H, Lupien M, Wu T, Regan MM, Meyer CA, Carroll JS, Manrai AK, Janne OA, Balk SP, Mehra R, Han B, Chinnaiyan AM, Rubin MA, True L, Fiorentino M, Fiore C, Loda M, Kantoff PW, Liu XS, Brown M. 2009. Androgen receptor regulates a distinct transcription program in androgen-independent prostate cancer. Cell 138:245-256.
24. Watson PA, Chen YF, Balbas MD, Wongvipat J, Socci ND, Viale A, Kim K, Sawyers CL. 2010. Constitutively active androgen receptor splice variants expressed in castration-resistant prostate cancer require full-length androgen receptor. Proc Natl Acad Sci USA 107:16759-16765.
25. Wellner U, Schubert J, Burk UC, Schmalhofer O, Zhu F, Sonntag A, Waldvogel B, Vannier C, Darling D, Zur Hausen, Brunton A, Morton VG, Sansom J, Schuler O, Stemmler J, Herzberger MP, Hopt C, Keck U, Brabletz T, Brabletz S. 2009. The EMT-activator ZEB1 promotes tumorigenicity by repressing stemnessinhibiting microRNAs. Nat Cell Biol 11:1487-1495.
26. Yang KR, Mooney SM, Zarif JC, Coffey DS, Taichman RS, Pienta KJ. 2014. Niche inheritance: a cooperative pathway to enhance cancer cell fitness though ecosystem engineering. J Cell Biochem 115:1478-1485.
27. Zeng Y, He Y, Yang F, Mooney SM, Getzenberg RH, Orban J, Kulkarni P. 2011. The cancer/testis antigen prostate-associated gene 4 (PAGE4) is a highly intrinsically disordered protein. J Biol Chem 286:13985-13994.